Globeflex Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.2M Sell
12,909
-882
-6% -$452K 0.94% 29
2025
Q4
$7.75M Sell
13,791
-269
-2% -$153K 1.19% 17
2025
Q3
$7.23M Sell
14,060
-667
-5% -$291K 1.11% 14
2025
Q2
$4.62M Buy
14,727
+1,773
+14% +$532K 0.38% 65
2025
Q1
$3.95M Buy
12,954
+5
+0% +$1.68K 0.36% 69
2024
Q4
$4.3M Hold
12,949
0.36% 68
2024
Q3
$4.32M Hold
12,949
0.41% 59
2024
Q2
$5.33M Buy
12,949
+7,374
+132% +$2.92M 0.56% 45
2024
Q1
$2.25M Buy
5,575
+2,455
+79% +$863K 0.22% 115
2023
Q4
$957K Sell
3,120
-400
-11% -$108K 0.1% 193
2023
Q3
$853K Sell
3,520
-307
-8% -$78.5K 0.1% 195
2023
Q2
$919K Sell
3,827
-96
-2% -$19.9K 0.1% 184
2023
Q1
$738K Hold
3,923
0.09% 217
2022
Q4
$833K Sell
3,923
-113
-3% -$22.6K 0.11% 200
2022
Q3
$634K Hold
4,036
0.11% 228
2022
Q2
$604K Hold
4,036
0.15% 199
2022
Q1
$660K Hold
4,036
0.13% 197
2021
Q4
$878K Sell
4,036
-422
-9% -$88.4K 0.18% 176
2021
Q3
$844K Sell
4,458
-11,352
-72% -$2.07M 0.18% 180
2021
Q2
$2.79M Sell
15,810
-11,579
-42% -$2M 0.5% 46
2021
Q1
$4.49M Buy
27,389
+1,720
+7% +$263K 0.82% 11
2020
Q4
$3.57M Buy
25,669
+69
+0.3% +$8.7K 0.76% 16
2020
Q3
$2.86M Sell
25,600
-611
-2% -$70.6K 0.76% 12
2020
Q2
$2.44M Sell
26,211
-4,502
-15% -$383K 0.62% 22
2020
Q1
$2.25M Sell
30,713
-4,676
-13% -$406K 0.69% 13
2019
Q4
$2.98M Sell
35,389
-1,036
-3% -$80.2K 0.56% 23
2019
Q3
$3.06M Buy
36,425
+1,219
+3% +$92.1K 0.67% 21
2019
Q2
$2.3M Sell
35,206
-30
-0.1% -$1.73K 0.48% 37
2019
Q1
$2.08M Sell
35,236
-863
-2% -$51.5K 0.44% 49
2018
Q4
$1.91M Buy
36,099
+3,341
+10% +$183K 0.45% 53
2018
Q3
$1.96M Buy
+32,758
New +$1.79M 0.39% 65

Other funds holding MEDP

Globeflex Capital's MEDP Position: Q1 2026 in Review

Globeflex Capital reduced its Medpace (MEDP) stake by 6.4% in Q1 2026, selling an estimated $452K and leaving 12,909 shares worth $6.2M. The position accounts for 0.94% of the portfolio, ranked #29.

Globeflex Capital first reported a position in MEDP in Q3 2018 and has held it in 31 quarters since. The position peaked at $7.75M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Globeflex Capital held 12,909 shares of Medpace worth $6.2M as of Q1 2026.
  • Globeflex Capital sold 882 Medpace shares in Q1 2026, an estimated $452K.
  • Medpace made up 0.94% of Globeflex Capital's portfolio in Q1 2026, its #29 holding.
  • Globeflex Capital first reported a position in Medpace in Q3 2018 and has held it in 31 quarters since.
  • Globeflex Capital's Medpace position peaked at $7.75M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.